206.10 +2.45 (1.20%)
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
202.8
Today’s High
209.5
52 Week Low
182.55
52 Week High
289.15
206.90 +2.60 (1.27%)
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
202.45
Today’s High
209.75
52 Week Low
182.5
52 Week High
289.35
Key Metrics
- Market Cap (In Cr) 3973
- Beta 0.88
- Div. Yield (%) 1.47
- P/B 2.34
- TTM P/E 32.1
- Peg Ratio 1.42
- Sector P/E 13.82
- D/E -
- Open Price 204
- Prev Close 203.65
Analysis
Price Analysis
-
1 Week-5.79%
-
3 Months-9.64%
-
6 Month-6.2%
-
YTD-15.7%
-
1 Year-21.24%
Risk Meter
- 35% Low risk
- 35% Moderate risk
- 35% Balanced Risk
- 35% High risk
- 35% Extreme risk
Recos
15 Analysts
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- Strong Sell
- 0
- Sell
- 3
- Hold
- 8
- Buy
- 1
- Strong Buy
- 3
Rallis India News
Brokerage says to BUY this Rakesh Jhunjhunwala stock despite 18% fall in Q1
3 min read . 22 Jul 2022
Rakesh Jhunjhunwala stock 45% below 52-week high. Right time to accumulate?
2 min read . 01 Jul 2022
Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2022
- Total Revenue
- 2603.93
- Selling/ General/ Admin Expenses Total
- 394.76
- Depreciation/ Amortization
- 74.31
- Other Operating Expenses Total
- 101.76
- Total Operating Expense
- 2391.48
- Operating Income
- 212.46
- Net Income Before Taxes
- 222.41
- Net Income
- 164.2
- Diluted Normalized EPS
- 8.82
- Period
- 2022
- Total Assets
- 2858.04
- Total Liabilities
- 1161.38
- Total Equity
- 1696.65
- Tangible Book Valueper Share Common Eq
- 72.79
- Period
- 2022
- Cashfrom Operating Activities
- 165.82
- Cashfrom Investing Activities
- -104.2
- Cashfrom Financing Activities
- -61.44
- Net Changein Cash
- 0.27
- Period
- 2021
- Total Revenue
- 2429.44
- Selling/ General/ Admin Expenses Total
- 386.33
- Depreciation/ Amortization
- 64.07
- Other Operating Expenses Total
- 83.87
- Total Operating Expense
- 2157.43
- Operating Income
- 272
- Net Income Before Taxes
- 303.5
- Net Income
- 228.57
- Diluted Normalized EPS
- 11.66
- Period
- 2021
- Total Assets
- 2588.62
- Total Liabilities
- 997.82
- Total Equity
- 1590.8
- Tangible Book Valueper Share Common Eq
- 68.15
- Period
- 2021
- Cashfrom Operating Activities
- 216.79
- Cashfrom Investing Activities
- -161.55
- Cashfrom Financing Activities
- -67.42
- Net Changein Cash
- -12.18
- Period
- 2020
- Total Revenue
- 2251.82
- Selling/ General/ Admin Expenses Total
- 356.57
- Depreciation/ Amortization
- 61.47
- Other Operating Expenses Total
- 83.3
- Total Operating Expense
- 2027.67
- Operating Income
- 224.15
- Net Income Before Taxes
- 237.49
- Net Income
- 184.84
- Diluted Normalized EPS
- 9.13
- Period
- 2020
- Total Assets
- 2448.48
- Total Liabilities
- 1039.03
- Total Equity
- 1409.45
- Tangible Book Valueper Share Common Eq
- 59.5
- Period
- 2020
- Cashfrom Operating Activities
- 336.84
- Cashfrom Investing Activities
- -245.92
- Cashfrom Financing Activities
- -74.41
- Net Changein Cash
- 16.51
- Period
- 2019
- Total Revenue
- 1983.96
- Selling/ General/ Admin Expenses Total
- 349.28
- Depreciation/ Amortization
- 46
- Other Operating Expenses Total
- 68.78
- Total Operating Expense
- 1781.29
- Operating Income
- 202.67
- Net Income Before Taxes
- 220.26
- Net Income
- 155.38
- Diluted Normalized EPS
- 8.13
- Period
- 2019
- Total Assets
- 2162.61
- Total Liabilities
- 876.69
- Total Equity
- 1285.93
- Tangible Book Valueper Share Common Eq
- 53.61
- Period
- 2019
- Cashfrom Operating Activities
- 80.06
- Cashfrom Investing Activities
- -51.45
- Cashfrom Financing Activities
- -51.5
- Net Changein Cash
- -22.89
- Period
- 2018
- Total Revenue
- 1808.46
- Selling/ General/ Admin Expenses Total
- 313.18
- Depreciation/ Amortization
- 46.23
- Other Operating Expenses Total
- 59.65
- Total Operating Expense
- 1589.01
- Operating Income
- 219.45
- Net Income Before Taxes
- 227.02
- Net Income
- 167.61
- Diluted Normalized EPS
- 8.62
- Period
- 2018
- Total Assets
- 1998.59
- Total Liabilities
- 808.02
- Total Equity
- 1190.57
- Tangible Book Valueper Share Common Eq
- 48.93
- Period
- 2018
- Cashfrom Operating Activities
- 41.39
- Cashfrom Investing Activities
- 88.8
- Cashfrom Financing Activities
- -104.14
- Net Changein Cash
- 26.04
- Period
- 2017
- Total Revenue
- 1768.2
- Selling/ General/ Admin Expenses Total
- 298.44
- Depreciation/ Amortization
- 47.47
- Other Operating Expenses Total
- 59.27
- Total Operating Expense
- 1388.32
- Operating Income
- 379.88
- Net Income Before Taxes
- 379.95
- Net Income
- 297.46
- Diluted Normalized EPS
- 8.96
- Period
- 2017
- Total Assets
- 1732.71
- Total Liabilities
- 621.55
- Total Equity
- 1111.16
- Tangible Book Valueper Share Common Eq
- 44.95
- Period
- 2017
- Cashfrom Operating Activities
- 407.66
- Cashfrom Investing Activities
- -289.42
- Cashfrom Financing Activities
- -79.69
- Net Changein Cash
- 38.54
- Period
- 2022-12-31
- Total Revenue
- 630.39
- Selling/ General/ Admin Expenses Total
- 64.53
- Depreciation/ Amortization
- 22.03
- Other Operating Expenses Total
- 130.47
- Total Operating Expense
- 599.11
- Operating Income
- 31.28
- Net Income Before Taxes
- 29.97
- Net Income
- 22.55
- Diluted Normalized EPS
- 1.16
- Period
- 2022-12-31
- Period
- 2022-12-31
- Period
- 2022-09-30
- Total Revenue
- 951.18
- Selling/ General/ Admin Expenses Total
- 64.5
- Depreciation/ Amortization
- 22.03
- Other Operating Expenses Total
- 144.2
- Total Operating Expense
- 855.6
- Operating Income
- 95.58
- Net Income Before Taxes
- 95.41
- Net Income
- 71.05
- Diluted Normalized EPS
- 3.65
- Period
- 2022-09-30
- Total Assets
- 3142.03
- Total Liabilities
- 1368.09
- Total Equity
- 1773.94
- Tangible Book Valueper Share Common Eq
- 76.75
- Period
- 2022-09-30
- Cashfrom Operating Activities
- -124.89
- Cashfrom Investing Activities
- 116.47
- Cashfrom Financing Activities
- 5.21
- Net Changein Cash
- -3.21
- Period
- 2022-06-30
- Total Revenue
- 862.78
- Selling/ General/ Admin Expenses Total
- 65.98
- Depreciation/ Amortization
- 24.67
- Other Operating Expenses Total
- 130.6
- Total Operating Expense
- 774.17
- Operating Income
- 88.61
- Net Income Before Taxes
- 90.96
- Net Income
- 67.47
- Diluted Normalized EPS
- 3.45
- Period
- 2022-06-30
- Period
- 2022-06-30
- Period
- 2022-03-31
- Total Revenue
- 507.54
- Selling/ General/ Admin Expenses Total
- 55.21
- Depreciation/ Amortization
- 19.66
- Other Operating Expenses Total
- 124.12
- Total Operating Expense
- 530.05
- Operating Income
- -22.5
- Net Income Before Taxes
- -16.25
- Net Income
- -14.19
- Diluted Normalized EPS
- -0.73
- Period
- 2022-03-31
- Total Assets
- 2858.04
- Total Liabilities
- 1161.38
- Total Equity
- 1696.65
- Tangible Book Valueper Share Common Eq
- 72.79
- Period
- 2022-03-31
- Cashfrom Operating Activities
- 165.82
- Cashfrom Investing Activities
- -104.2
- Cashfrom Financing Activities
- -61.44
- Net Changein Cash
- 0.27
- Period
- 2021-12-31
- Total Revenue
- 628.08
- Selling/ General/ Admin Expenses Total
- 62.28
- Depreciation/ Amortization
- 18.42
- Other Operating Expenses Total
- 122.92
- Total Operating Expense
- 579.1
- Operating Income
- 48.98
- Net Income Before Taxes
- 53.07
- Net Income
- 39.56
- Diluted Normalized EPS
- 2.03
- Period
- 2021-12-31
- Period
- 2021-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Technical
Moving Average
SMA
- 5 Day211.04
- 10 Day222.3
- 20 Day233.77
- 50 Day240.13
- 100 Day231.66
- 300 Day223.81
Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Sharda Cropchem
- 484.75
- 8.45
- 1.77
- 767.7
- 368.8
- 4296.75
- Meghmani Finechem
- 1050.4
- 23.45
- 2.28
- 1736.6
- 741.1
- 4271.98
- Rallis India
- 206.1
- 2.45
- 1.2
- 289.15
- 182.55
- 3973
- Privi Speciality Chemicals
- 1000.75
- 1.2
- 0.12
- 2193.8
- 986.95
- 3903.93
- Rossari Biotech
- 688.05
- -2.35
- -0.34
- 1250
- 675
- 3810.69
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Sharda Cropchem
- 11.56
- 2.25
- 16.16
- 9.5
- Meghmani Finechem
- 16.9
- 5.88
- -
- -
- Rallis India
- 23.17
- 2.34
- 13.09
- 8.11
- Privi Speciality Chemicals
- 41.76
- 4.81
- 16.8
- 7.95
- Rossari Biotech
- 41.12
- 4.72
- 23.46
- 8.71
Shareholding
- Category
- Percentage
- No. of shares
- Public Shareholding
- 49.91%
- 97,052,280
- Others
- 13.06%
- 25,397,543
- Sbi Long Term Equity Fund
- 5.01%
- 9,738,169
- Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund
- 3.9%
- 7,586,219
- Canara Robeco Mutual Fund A/C Canara Robeco Small Cap Fund
- 1.49%
- 2,906,134
- Others
- 2.41%
- 4,681,564
- Rekha Rakesh Jhunjhunwala
- 5.52%
- 10,735,570
- Rekha Jhunjhunwala
- 2.67%
- 5,182,750
- Rakesh Jhunjhunwala
- 2.11%
- 4,100,000
- Others
- 0.98%
- 1,924,422
- Steinberg India Emerging Opportunities Fund Limited
- 1.18%
- 2,300,000
- Others
- 5.82%
- 11,310,518
- Others
- 2.04%
- 3,960,740
- Others
- 1.27%
- 2,463,212
- Others
- 0.86%
- 1,663,333
- HUF
- 0.58%
- 1,131,208
- LLP
- 0.1%
- 195,051
- Clearing Members
- 0.02%
- 39,989
- Director or Director's Relatives
- 0%
- 4,835
- Trusts
- 0%
- 1,050
- Others
- 0.45%
- 883,061
- Others
- 0.41%
- 801,150
- Others
- 0.02%
- 35,199
- Others
- 0%
- 5,810
- Others
- 0%
- 4,454
- Others
- 0%
- 299
- Promoter & Promoter Group Shareholding
- 50.09%
- 97,416,610
- Tata Chemicals Limited
- 50.06%
- 97,341,610
- Ewart Investments Limited
- 0.04%
- 75,000
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 18-Jan-23
- Quarterly Results
- 19-Oct-22
- Quarterly Results
- 19-Jul-22
- Quarterly Results
- 21-Apr-22
- Audited Results & Final Dividend
- 19-Jan-22
- Quarterly Results
- 19-Oct-21
- Quarterly Results
- 21-Jul-21
- Quarterly Results
- 22-Apr-21
- Audited Results & Final Dividend
- 18-Jan-21
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 24-Jun-22
- 27-Apr-22
- AGM
- 24-Jun-21
- 22-Apr-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 21-Apr-22
- -
- 06-Jun-22
- 3
- 22-Apr-21
- -
- 09-Jun-21
- 3
No recent bonus announcements.
No recent splits available.
No recent rights issue declared.
Company Profile
ABOUT Rallis India
- Industry Chemical Manufacturing
- ISIN INE613A01020
- BSE Code 500355
- NSE Code RALLIS
Rallis India Limited is an India-based company, which is engaged primarily in the business of manufacturing and marketing of agri-inputs. The agri-inputs consists of crop protection products, plant growth nutrients, organic compost and processing of seeds and provides agri-solutions under its Rallis Samrudh Krishi (RSK) initiative. Its business areas include domestic crop protection, international business, contract manufacturing, seeds, plant growth nutrients and agri-services. It offers crop protection products, such as fungicides, herbicides, insecticides, PCO-pesticides. It is engaged in the business segments of crop protection chemicals, specialty chemicals, polymers and intermediates through contract manufacturing. Its seed division is an agricultural biotechnology company focusing on developing traits and technologies for crop protection and improved productivity. Its plant growth nutrients products include Gluco Beta, Ralligold, Solubor and Tata Bahaar, among others.
MANAGEMENT
- Sanjiv Lal Chief Executive Officer, Managing Director, Executive Director
- Subhra Gourisaria Chief Financial Officer
- Srikant Nair Compliance Officer, Company Secretary
Company Summary
RALLIS INDIA SUMMARY
Rallis India is trading 1.20% upper at Rs 206.10 as compared to its last closing price. Rallis India has been trading in the price range of 209.5 & 202.8. Rallis India has given -15.7% in this year & -5.79% in the last 5 days.
Rallis India has TTM P/E ratio 32.1 as compared to the sector P/E of 13.82. There are 15 analysts who have initiated coverage on Rallis India. There are 3 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.
The company posted a net profit of 22.55 Crores in its last quarter.
Listed peers of Rallis India include Sharda Cropchem (1.77%), Meghmani Finechem (2.28%), Rallis India (1.2%) etc.
Rallis India has a 50.09% promoter holding & 49.91% public holding.
FAQs about Rallis India
Rallis India is trading at 206.10 as on 2 Feb, 2023 3:27:19 PM. This is 1.20% upper as compared to its previous closing price of 203.65
The market capitalization of Rallis India is 3973 Cr as on 2 Feb, 2023 3:27:19 PM.
The average broker rating on Rallis India is Hold. The breakup of analyst rating is given below -
- 0 analysts have given a strong sell rating
- 3 analysts have given a sell rating
- 8 analysts have given a hold rating
- 1 analysts have given a buy rating
- 3 analysts have given a strong buy rating
The 52 wk high for Rallis India is 289.15 whereas the 52 wk low is 182.55
Rallis India can be analyzed on the following key metrics -
- TTM P/E: 32.1
- Sector P/E: 13.82
- Dividend Yield: 1.47%
- D/E ratio: -
Rallis India reported a net profit of 164.2 Cr in 2022.
